To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MYO19TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
468 supporting clones for gene MYO19 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX333876 Neuroblastoma Cot 50-normalized .a 1 to 940 5 to 938       938/938
(100 %)
11 diff
(98.9 %id)
BC008900 Placenta, choriocarcinoma .a 2 to 3792 1 to 3191 Q440L H441E F442A V443C A444G ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3191/3191
(100 %)
1 diff
(100.0 %id)
AK304073 trachea .a 42 to 3686 1 to 3645 L271S L863F tiling clone,   3645/3645
(100 %)
3 diff
(100.0 %id)
CX758743 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1646 to 2380 38 to 771     Submitted on the opposite strand 734/771
(95 %)
7 diff
(99.1 %id)
DA480263   .a 1774 to 2334 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BF968765 adrenal cortex carcinoma, cell line, adrenal gland .a 1827 to 2638 1 to 817       817/934
(87 %)
17 diff
(98.2 %id)
TI_154172249   .a 1849 to 2463 78 to 691       614/615
(99 %)
9 diff
(98.6 %id)
CF141468 CNCAP(3)T-225 cell line, Prostate .a 1850 to 2321 8 to 479       474/479
(98 %)
8 diff
(98.4 %id)
BQ223710 large cell carcinoma, lung .a 1908 to 2634 1 to 731       731/936
(78 %)
11 diff
(98.9 %id)
BP313004 mammary gland .a 1965 to 2546 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
TI_59386855   .a 2022 to 2647 103 to 728       626/628
(99 %)
1 diff
(99.9 %id)
BF809629 colon_ins .a 2027 to 2511 497 to 14     Submitted on the opposite strand 483/505
(95 %)
5 diff
(99.1 %id)
BM020622 astrocytoma grade IV, cell line, brain .a 2027 to 2647 7 to 627       621/629
(98 %)
7 diff
(98.9 %id)
BG116975 duodenal adenocarcinoma, cell line, small intestine .a 2035 to 2758 1 to 722       722/796
(90 %)
16 diff
(98.0 %id)
BG116913 duodenal adenocarcinoma, cell line, small intestine .a 2035 to 2762 1 to 748       718/993
(72 %)
68 diff
(93.2 %id)
BM472355 melanotic melanoma, skin .a 2114 to 2761 1 to 648       648/1020
(63 %)
2 diff
(99.9 %id)
BX327604 Neuroblastoma Cot 25-normalized .a 2124 to 3034 1 to 915       915/919
(99 %)
42 diff
(95.5 %id)
BU196917 ductal carcinoma, cell line, Pancreas .a 2142 to 2984 1 to 854       854/909
(93 %)
26 diff
(97.2 %id)
BG744021 blood, natural killer cells, cell line .a 2146 to 2890 1 to 740       740/745
(99 %)
9 diff
(98.8 %id)
BP266991 thyroid .a 2237 to 2808 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BU543266 carcinoma, cell line, Prostate .a 2252 to 3142 1 to 889       889/895
(99 %)
12 diff
(98.7 %id)
TI_1948149199   .a 2299 to 3296 1122 to 128       995/1340
(74 %)
14 diff
(99.0 %id)
BI870002 adenocarcinoma, cell line, Liver .a 2307 to 3077 1 to 771       771/771
(100 %)
4 diff
(99.5 %id)
TI_57229592   .a 2307 to 3077 88 to 858       771/771
(100 %)
4 diff
(99.5 %id)
BP234010 coronary artery .a 2312 to 2890 1 to 579       579/583
(99 %)
2 diff
(99.7 %id)
DR156266 human embryonic stem cells differentiated toan early endodermal cell type .a 2360 to 3012 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
TI_1948148873   .a 2367 to 3296 1056 to 131   tiling clone,   926/1344
(68 %)
14 diff
(99.0 %id)
BG676932 skin, squamous cell carcinoma .a 2433 to 3274 1 to 848       848/854
(99 %)
9 diff
(99.0 %id)
BG744691 blood, natural killer cells, cell line .a 2949 to 3721 798 to 24       775/800
(96 %)
6 diff
(99.3 %id)
BX386973 Neuroblastoma Cot 50-normalized .a 2974 to 3880 911 to 1       911/911
(100 %)
19 diff
(98.0 %id)
BE621607 epithelioid carcinoma, Pancreas .a 3133 to 3889 766 to 8       759/1044
(72 %)
0 diff
(100 %id)
TI_149297311   .a 3138 to 3910 852 to 83   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 770/921
(83 %)
7 diff
(99.3 %id)
BQ181670 Knee, Osteoarthritic Cartilage .a 3178 to 3792 633 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 615/615
(100 %)
0 diff
(100 %id)
BU627174 Bone, Enchondroma cell line .a 3212 to 3910 717 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 699/699
(100 %)
1 diff
(99.9 %id)
CD367865 Alveolar Macrophage, lung .a 3212 to 3792 599 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 581/581
(100 %)
8 diff
(98.7 %id)
AA416825   .a 3215 to 3572 1 to 358   fully sequenced,   358/358
(100 %)
5 diff
(98.7 %id)
BM982398 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3225 to 3910 698 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 686/686
(100 %)
0 diff
(100 %id)
BQ009450 Chondrosarcoma, Left Pubic Bone .a 3228 to 3910 695 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 683/683
(100 %)
0 diff
(100 %id)
CB306577 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3243 to 3910 680 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 668/668
(100 %)
0 diff
(100 %id)
AY545559 head; neck .a 3255 to 3555 1 to 301       301/308
(97 %)
6 diff
(98.1 %id)
CB159365 Liver .a 3265 to 3811 1 to 547       547/547
(100 %)
0 diff
(100 %id)
CA445619 Chondrosarcoma, Left Pubic Bone .a 3282 to 3792 528 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 510/510
(100 %)
1 diff
(99.9 %id)
BQ182953 Chondrosarcoma, Left Pubic Bone .a 3290 to 3910 633 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 621/621
(100 %)
0 diff
(100 %id)
CA425709 cell lines, Chondrosarcoma .a 3308 to 3914 625 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 607/607
(100 %)
0 diff
(100 %id)
BE465496 malignant melanoma, metastatic to lymphnode, skin .a 3322 to 3793 473 to 2       472/473
(99 %)
0 diff
(100 %id)
AA994178   .a 3343 to 3789 447 to 2       446/447
(99 %)
0 diff
(100 %id)
AI694002 colon .a 3351 to 3907 557 to 1       557/557
(100 %)
2 diff
(99.7 %id)
AW028389 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3359 to 3792 433 to 1       433/433
(100 %)
1 diff
(99.8 %id)
AW005600 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3383 to 3793 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AI028762   .a 3389 to 3788 400 to 1       400/400
(100 %)
2 diff
(99.5 %id)
AW005609 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3402 to 3793 392 to 1       392/392
(100 %)
0 diff
(100 %id)
DW441273 Liver .a 3417 to 3639 17 to 239       223/239
(93 %)
6 diff
(97.5 %id)
DW449268 Liver .a 3417 to 3604 17 to 204       188/204
(92 %)
6 diff
(97.1 %id)
AA641286 invasive tumor (cell line), Prostate .a 3421 to 3705 285 to 1       285/285
(100 %)
0 diff
(100 %id)
BF084132 colon .a 3422 to 3862 68 to 510       443/510
(86 %)
6 diff
(98.9 %id)
AA872644 Kidney .a 3423 to 3912 491 to 2       490/491
(99 %)
0 diff
(100 %id)
AA856599 Kidney .a 3423 to 3793 376 to 7       370/376
(98 %)
0 diff
(100 %id)
AW074429 colon, juvenile granulosa tumor .a 3440 to 3787 348 to 1       348/348
(100 %)
0 diff
(100 %id)
AI588937 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3445 to 3910 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AA812539   .a 3451 to 3912 464 to 3       462/464
(99 %)
0 diff
(100 %id)
AI362984 anaplastic oligodendroglioma, brain .a 3459 to 3910 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI168838 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3465 to 3910 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AI378368 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3468 to 3911 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AI347827 2 pooled tumors (clear cell type), Kidney .a 3477 to 3913 442 to 6       437/442
(98 %)
0 diff
(100 %id)
H15805 whole brain .a 3497 to 3910 434 to 20   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 415/415
(100 %)
6 diff
(98.6 %id)
AA416694   .a 3542 to 3800 259 to 1   fully sequenced,   259/259
(100 %)
4 diff
(98.5 %id)
AA552691 colon, tumor .a 3543 to 3850 308 to 1       308/308
(100 %)
1 diff
(99.7 %id)
AA888152 2 pooled tumors (clear cell type), Kidney .a 3543 to 3912 371 to 2       370/371
(99 %)
0 diff
(100 %id)
AA938635 2 pooled tumors (clear cell type), Kidney .a 3543 to 3910 369 to 2       368/369
(99 %)
0 diff
(100 %id)
FN114621 breast carcinoma .a 3547 to 3620 1 to 75       75/75
(100 %)
6 diff
(92.0 %id)
AA055511 heart .a 3554 to 3732 1 to 182   fully sequenced,   182/182
(100 %)
0 diff
(100 %id)
AI540615 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3563 to 3792 230 to 1       230/230
(100 %)
0 diff
(100 %id)
AA515605 colon .a 3592 to 3787 196 to 1       196/196
(100 %)
0 diff
(100 %id)
CX782561 human embryonic stem cells .a 3606 to 3914 335 to 26   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 310/310
(100 %)
14 diff
(95.5 %id)
FN142554 breast carcinoma .a 3622 to 3734 1 to 114       114/115
(99 %)
2 diff
(98.3 %id)
BF508280   .a 3634 to 3912 294 to 16       279/294
(94 %)
0 diff
(100 %id)
AA977374 2 pooled tumors (clear cell type), Kidney .a 3636 to 3906 271 to 1       271/271
(100 %)
0 diff
(100 %id)
AA677972 liver and spleen .a 3659 to 3904 246 to 1       246/246
(100 %)
1 diff
(99.6 %id)
AI302293 2 pooled tumors (clear cell type), Kidney .a 3661 to 3912 253 to 2       252/253
(99 %)
0 diff
(100 %id)
AA055512 heart .a 3702 to 3910 210 to 1   fully sequenced,   210/210
(100 %)
0 diff
(100 %id)
BP384276 pancreatic islet .a 3731 to 4048 497 to 179       319/502
(63 %)
0 diff
(100 %id)
BP387045 pancreatic islet .a 3733 to 4001 269 to 1       269/270
(99 %)
0 diff
(100 %id)
AA134847 lung, lung carcinoma .a 3867 to 4329 1 to 461   tiling clone,   461/464
(99 %)
12 diff
(97.5 %id)
AA703821   .a 3867 to 4256 1 to 390   tiling clone,   390/390
(100 %)
0 diff
(100 %id)
FN065267 breast carcinoma .a 3884 to 3966 1 to 85       85/86
(98 %)
4 diff
(95.4 %id)
FN132362 breast carcinoma .a 3997 to 4103 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
FN104708 breast carcinoma .a 4071 to 4133 1 to 62       62/63
(98 %)
2 diff
(96.9 %id)
FN152329 breast carcinoma .a 4106 to 4194 1 to 87       87/87
(100 %)
6 diff
(93.2 %id)
DC321557 brain .b 1 to 545 1 to 545   tiling clone,   545/545
(100 %)
1 diff
(99.9 %id)
AK293903 cerebellum .b 340 to 5482 1 to 4292 T291D R292G L293V L294E Q295E ... tiling clone, Suspected internal deletion, suspected internal deletion 4292/4294
(99 %)
5 diff
(99.9 %id)
AB209035 brain .c 1 to 5762 1 to 5743 N176S tiling clone, Suspected internal deletion 5743/5743
(100 %)
3 diff
(100.0 %id)
DC317607 amygdala .c 448 to 997 1 to 550   tiling clone,   550/550
(100 %)
0 diff
(100 %id)
DC415720 trachea .c 471 to 1023 1 to 553       553/553
(100 %)
2 diff
(99.7 %id)
BP321007 placenta .c 487 to 1034 1 to 550       550/550
(100 %)
20 diff
(96.4 %id)
DC311602 alzheimer cortex .c 491 to 1051 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DC324955 brain .c 491 to 1061 1 to 571       571/572
(99 %)
4 diff
(99.4 %id)
DC333597 hippocampus .c 491 to 1044 1 to 554       554/554
(100 %)
0 diff
(100 %id)
DC346591 tongue, tumor tissue .c 491 to 1079 1 to 589       589/589
(100 %)
2 diff
(99.7 %id)
BP321008 placenta .c 491 to 1080 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
DC411091 thymus .c 491 to 1069 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
DC422459 uterus .c 491 to 1033 1 to 543       543/543
(100 %)
0 diff
(100 %id)
DC423166 uterus .c 491 to 1041 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
BP348473 brain .c 493 to 1075 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DC384821   .c 495 to 1031 1 to 537       537/537
(100 %)
1 diff
(99.9 %id)
DC309240 cerebellum .c 498 to 1043 1 to 546       546/546
(100 %)
2 diff
(99.7 %id)
DC377673 brain .c 516 to 1047 1 to 532       532/532
(100 %)
0 diff
(100 %id)
DB272719 uterus .c 519 to 1036 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
DA952102 Spleen .c 524 to 1094 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BM921100 pooled brain, lung, testis .c 526 to 1361 1 to 844       844/1052
(80 %)
20 diff
(98.1 %id)
DA331860 hippocampus .c 535 to 1061 2 to 528   capped   527/531
(99 %)
3 diff
(99.5 %id)
BQ063197 lymph, lymphoma, cell line .c 537 to 1500 1 to 972       972/1014
(95 %)
21 diff
(98.0 %id)
CD656712 Embryonic Stem cells .c 539 to 1185 11 to 658       648/808
(80 %)
35 diff
(95.7 %id)
DB032417 testis .c 539 to 1031 2 to 494   capped   493/493
(100 %)
2 diff
(99.6 %id)
DA768936 brain .c 540 to 1061 2 to 523   capped   522/525
(99 %)
2 diff
(99.7 %id)
DB284834 uterus .c 549 to 1090 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DA327661 hippocampus .c 557 to 1031 2 to 476   capped   475/475
(100 %)
1 diff
(99.8 %id)
BP357441 mammary gland .c 562 to 1143 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB075294 testis .c 565 to 1101 2 to 538   capped   537/537
(100 %)
4 diff
(99.3 %id)
BP315385 mammary gland .c 566 to 1147 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP367395 thymus .c 566 to 1146 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CB151114 cervix, Uterine .c 568 to 1113 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
CN366390 embryonic stem cells, cell lines H1, H7, andH9 .c 568 to 1113 1 to 546       546/546
(100 %)
2 diff
(99.7 %id)
BP313052 mammary gland .c 568 to 1153 1 to 583       583/583
(100 %)
7 diff
(98.8 %id)
DA446376 tongue, tumor tissue .c 569 to 1134 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA446834 tongue, tumor tissue .c 569 to 1145 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA456604 tongue, tumor tissue .c 569 to 1147 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA460687 tongue, tumor tissue .c 569 to 1126 2 to 560   capped   559/562
(99 %)
5 diff
(99.2 %id)
DA472831   .c 569 to 1125 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA478306   .c 569 to 1135 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BP314622 mammary gland .c 569 to 1150 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA992466 synovial membrane tissue from rheumatioidarthritis .c 569 to 1124 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB286958 uterus .c 569 to 1121 2 to 555   capped   554/555
(99 %)
3 diff
(99.5 %id)
DA433868 tongue, tumor tissue .c 570 to 1149 2 to 581   to resequence, capped   580/580
(100 %)
1 diff
(99.9 %id)
DB152195 thymus .c 570 to 1156 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA460431 tongue, tumor tissue .c 571 to 1141 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
DB449090 testis .c 571 to 1003 1 to 432       432/432
(100 %)
1 diff
(99.8 %id)
DA316630 hippocampus .c 572 to 1126 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA941361 Spleen .c 573 to 1155 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA691887   .c 576 to 1097 2 to 526   capped   525/525
(100 %)
4 diff
(99.3 %id)
BP357219 mammary gland .c 586 to 1166 1 to 582       582/582
(100 %)
13 diff
(97.8 %id)
BP357253 mammary gland .c 586 to 1167 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA054199 cerebellum .c 587 to 1119 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
BX457543 neuroblastoma .c 587 to 1586 1 to 997       997/997
(100 %)
4 diff
(99.6 %id)
AL523789 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 587 to 1518 1 to 926       926/984
(94 %)
10 diff
(99.0 %id)
BX345099 Neuroblastoma Cot 25-normalized .c 587 to 1382 1 to 792       792/793
(99 %)
7 diff
(99.2 %id)
BX366060 Neuroblastoma Cot 25-normalized .c 587 to 1518 1 to 926       926/926
(100 %)
17 diff
(98.2 %id)
DA461974 tongue, tumor tissue .c 587 to 1142 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BG480040 choriocarcinoma, placenta .c 587 to 1353 1 to 767       767/768
(99 %)
13 diff
(98.4 %id)
BQ953514 epidermoid carcinoma, cell line, lung .c 588 to 1274 24 to 710       687/1029
(66 %)
14 diff
(98.7 %id)
BP313554 mammary gland .c 588 to 1170 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BQ054212 blood, natural killer cells, cell line .c 589 to 1525 1 to 947       947/1035
(91 %)
21 diff
(98.0 %id)
BQ935094 epidermoid carcinoma, cell line, lung .c 589 to 1215 1 to 633       633/1066
(59 %)
12 diff
(98.9 %id)
BQ960461 epidermoid carcinoma, cell line, lung .c 589 to 1384 1 to 797       797/856
(93 %)
8 diff
(99.1 %id)
BU527269 epidermoid carcinoma, cell line, lung .c 589 to 1444 1 to 863       863/864
(99 %)
11 diff
(98.8 %id)
BU527354 epidermoid carcinoma, cell line, lung .c 589 to 1427 1 to 844       844/844
(100 %)
5 diff
(99.5 %id)
BU529006 epidermoid carcinoma, cell line, lung .c 589 to 1247 1 to 664       664/971
(68 %)
9 diff
(99.1 %id)
BP235254 coronary artery .c 591 to 1178 1 to 587       587/587
(100 %)
11 diff
(98.2 %id)
BP314794 mammary gland .c 591 to 1171 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DA462262 tongue, tumor tissue .c 593 to 1116 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
BM510460 insulinoma, Pancreas .c 595 to 1031 1 to 437       437/437
(100 %)
6 diff
(98.7 %id)
BM043396 carcinoma, cell line, Prostate .c 596 to 1369 1 to 772       772/772
(100 %)
6 diff
(99.3 %id)
BM047312 carcinoma, cell line, Prostate .c 596 to 1468 1 to 866       864/872
(99 %)
23 diff
(97.4 %id)
BE783284 eye, retinoblastoma .c 602 to 1291 1 to 686       689/687
(100 %)
10 diff
(98.6 %id)
TI_57232353   .c 603 to 1231 72 to 700       629/700
(89 %)
6 diff
(99.2 %id)
BI906430 leukocyte .c 604 to 1231 1 to 628       628/628
(100 %)
0 diff
(100 %id)
BE409176 choriocarcinoma, placenta .c 607 to 1181 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BM453458 leiomyosarcoma, uterus .c 607 to 1022 1 to 422   AAA   422/1051
(40 %)
7 diff
(99.4 %id)
CB959952 Human Placenta, placenta .c 618 to 1305 29 to 722       694/765
(90 %)
14 diff
(98.2 %id)
BP315650 mammary gland .c 618 to 1199 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB225405 trachea .c 620 to 1176 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA095047 cerebellum .c 626 to 1179 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA456212 tongue, tumor tissue .c 627 to 1193 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA456482 tongue, tumor tissue .c 627 to 1196 2 to 571   capped   570/571
(99 %)
1 diff
(99.9 %id)
CN482232 eye .c 627 to 1079 1 to 453       453/453
(100 %)
0 diff
(100 %id)
DA708611   .c 627 to 1183 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DB217337 trachea .c 629 to 1191 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BX333764 Neuroblastoma Cot 50-normalized .c 637 to 1595 1 to 955       955/1023
(93 %)
15 diff
(98.6 %id)
TI_57172469   .c 638 to 1239 21 to 621       601/621
(96 %)
13 diff
(98.0 %id)
BI828746 brain, medulla .c 643 to 1239 1 to 595       595/595
(100 %)
10 diff
(98.4 %id)
BG827677 muscle, rhabdomyosarcoma .c 646 to 1374 1 to 741       741/779
(95 %)
25 diff
(96.8 %id)
AL602190   .c 672 to 1372 1 to 701       701/701
(100 %)
1 diff
(99.9 %id)
CN366386 embryonic stem cells, cell lines H1, H7, andH9 .c 716 to 1211 1 to 498       498/498
(100 %)
4 diff
(99.2 %id)
BQ215709 melanotic melanoma, skin .c 790 to 1585 28 to 830       803/915
(87 %)
17 diff
(98.2 %id)
BP313962 mammary gland .c 825 to 1406 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CO245742 Chondrosarcoma Lung Metastasis cell lines, lung .c 826 to 1449 8 to 632       625/831
(75 %)
17 diff
(98.0 %id)
BF351795 head_neck .c 838 to 1168 381 to 48       334/396
(84 %)
3 diff
(99.3 %id)
BG111251 Bone, osteosarcoma, cell line .c 841 to 1518 1 to 671       671/920
(72 %)
13 diff
(98.6 %id)
BQ650642 hepatocellular carcinoma, cell line, Liver .c 842 to 1695 1 to 850       850/925
(91 %)
30 diff
(96.8 %id)
BQ050997 leiomyosarcoma, uterus .c 855 to 1694 1 to 839       839/1017
(82 %)
26 diff
(97.5 %id)
BQ059297 lymph, lymphoma, cell line .c 865 to 1868 1 to 1005       1005/1005
(100 %)
13 diff
(98.8 %id)
BQ064881 lymph, lymphoma, cell line .c 865 to 1779 1 to 919       919/969
(94 %)
16 diff
(98.4 %id)
CN366389 embryonic stem cells, cell lines H1, H7, andH9 .c 924 to 1375 211 to 663       453/470
(96 %)
7 diff
(98.6 %id)
BM913759 astrocytoma grade IV, cell line, brain .c 929 to 1695 1 to 773       773/1110
(69 %)
28 diff
(97.5 %id)
CV027205 mixed .c 971 to 1553 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
TI_1948148280   .c 971 to 1372 126 to 527       402/1417
(28 %)
10 diff
(99.3 %id)
TI_1948148281   .c 971 to 1595 128 to 754       627/1378
(45 %)
19 diff
(98.7 %id)
TI_1948148580   .c 971 to 1519 122 to 675       554/1263
(43 %)
13 diff
(99.0 %id)
TI_1948148581   .c 971 to 1787 131 to 950       820/1384
(59 %)
21 diff
(98.5 %id)
TI_1948148872   .c 971 to 2074 126 to 1221   tiling clone,   1098/1328
(82 %)
16 diff
(98.8 %id)
TI_1948149198   .c 971 to 2040 120 to 1185       1066/1328
(80 %)
30 diff
(97.8 %id)
TI_1948150100   .c 971 to 1695 130 to 859       730/1617
(45 %)
10 diff
(99.4 %id)
AL603338 human skeletal muscle .c 1010 to 1380 1 to 371       371/371
(100 %)
2 diff
(99.5 %id)
BM911378 amelanotic melanoma, cell line, skin .c 1011 to 1526 1 to 515       515/1237
(41 %)
27 diff
(97.9 %id)
BM911613 amelanotic melanoma, cell line, skin .c 1011 to 1588 1 to 583       583/1005
(58 %)
12 diff
(98.9 %id)
BM807349 amelanotic melanoma, cell line, skin .c 1011 to 1516 1 to 510       510/1233
(41 %)
12 diff
(99.1 %id)
BE896428 melanotic melanoma, skin .c 1028 to 1518 17 to 511       495/516
(95 %)
11 diff
(97.9 %id)
BF837752 head_neck .c 1043 to 1513 477 to 8     Submitted on the opposite strand 470/477
(98 %)
1 diff
(99.8 %id)
BQ362827 stomach .c 1062 to 1423 367 to 6       362/367
(98 %)
0 diff
(100 %id)
BE304619 adenocarcinoma cell line, colon .c 1109 to 1783 1 to 671       671/744
(90 %)
21 diff
(97.2 %id)
BP307057   .c 1148 to 1713 1 to 566       566/566
(100 %)
2 diff
(99.7 %id)
BE797194 lung, small cell carcinoma .c 1260 to 1954 1 to 696       694/976
(71 %)
35 diff
(96.5 %id)
EL593463 epidermis, skin .c 1267 to 1776 12 to 519       508/689
(73 %)
8 diff
(98.9 %id)
CN366387 embryonic stem cells, cell lines H1, H7, andH9 .c 1299 to 1991 19 to 713       695/713
(97 %)
8 diff
(98.9 %id)
CN366385 embryonic stem cells, cell lines H1, H7, andH9 .c 1351 to 1695 1 to 345       345/349
(98 %)
11 diff
(96.9 %id)
BG990445 head_neck .c 1397 to 1867 505 to 34       472/505
(93 %)
27 diff
(94.7 %id)
BE791484 lung, small cell carcinoma .c 1445 to 2206 1 to 771       771/1126
(68 %)
18 diff
(98.5 %id)
BE791843 lung, small cell carcinoma .c 1447 to 2206 1 to 755       757/968
(78 %)
27 diff
(97.3 %id)
CD656975 Embryonic Stem cells .c 1502 to 2278 5 to 775       771/813
(94 %)
17 diff
(98.0 %id)
CV811029 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 1523 to 2324 1 to 808   tiling clone,   808/884
(91 %)
14 diff
(98.5 %id)
CF122861 CNCAP(3)T-225 cell line, Prostate .c 1559 to 2188 7 to 638       632/638
(99 %)
3 diff
(99.6 %id)
CF122868 CNCAP(3)T-225 cell line, Prostate .c 1559 to 2079 7 to 528       522/528
(98 %)
2 diff
(99.7 %id)
TI_154182579   .c 1559 to 2332 65 to 842       778/826
(94 %)
11 diff
(98.7 %id)
TI_154182588   .c 1559 to 2324 72 to 837       766/840
(91 %)
13 diff
(98.5 %id)
BQ439359 embryonal carcinoma, cell line, testis .c 1595 to 2331 1 to 740       740/928
(79 %)
22 diff
(97.7 %id)
BP265225 thyroid .c 1622 to 2205 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BM193565 leukopheresis .c 1649 to 1973 1 to 325       325/326
(99 %)
3 diff
(99.1 %id)
BM144377 leukopheresis .c 1649 to 2082 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
BM145059 leukopheresis .c 1649 to 2144 1 to 497       497/497
(100 %)
2 diff
(99.6 %id)
BE243741 leukopheresis .c 1649 to 1770 1 to 122       122/122
(100 %)
4 diff
(96.8 %id)
TI_154182576   .c 1685 to 2275 189 to 788       607/859
(70 %)
64 diff
(92.6 %id)
BX280258 cervix .c 1716 to 2229 1 to 514       514/514
(100 %)
0 diff
(100 %id)
BI093751 cervix .c 1716 to 2372 1 to 660       658/663
(99 %)
6 diff
(99.1 %id)
BE273715 Kidney, renal cell adenocarcinoma .c 1740 to 2411 1 to 664       664/708
(93 %)
18 diff
(97.5 %id)
BP236364 coronary artery .c 1824 to 2405 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ892792 ductal carcinoma, cell line, Pancreas .c 1874 to 2615 1 to 745       745/860
(86 %)
9 diff
(99.0 %id)
BP235873 coronary artery .c 1938 to 2520 1 to 583       584/583
(100 %)
7 diff
(98.8 %id)
CX872659 embryonic stem .c 1992 to 2759 1 to 768   tiling clone,   768/768
(100 %)
0 diff
(100 %id)
BG323524 Kidney, renal cell adenocarcinoma .c 2000 to 2770 1 to 769       769/887
(86 %)
21 diff
(97.7 %id)
DA597131   .c 2014 to 2472 2 to 460   capped   459/459
(100 %)
2 diff
(99.6 %id)
BP284099 bone marrow .c 2020 to 2606 1 to 587       587/587
(100 %)
0 diff
(100 %id)
CX758784 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 2069 to 2755 1 to 687     Submitted on the opposite strand 687/687
(100 %)
0 diff
(100 %id)
CX753633 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 2174 to 2875 31 to 725   tiling clone, Submitted on the opposite strand 695/790
(87 %)
15 diff
(98.2 %id)
W20422 lung .c 2180 to 2511 1 to 331       331/331
(100 %)
6 diff
(98.2 %id)
AW361145 colon .c 2237 to 2661 430 to 1       430/430
(100 %)
8 diff
(98.2 %id)
BP872163 embryonal kidney .c 2263 to 2875 1 to 613   tiling clone,   613/624
(98 %)
6 diff
(99.1 %id)
AW806632 stomach .c 2344 to 2752 419 to 16       404/419
(96 %)
0 diff
(100 %id)
BQ368219 placenta_normal .c 2376 to 2736 30 to 389       358/389
(92 %)
13 diff
(96.7 %id)
N54761 multiple sclerosis lesions .c 2485 to 2745 1 to 260       260/260
(100 %)
2 diff
(99.3 %id)
AI905632 breast .c 2489 to 2832 353 to 8   tiling clone,   346/353
(98 %)
2 diff
(99.5 %id)
DA959914 Spleen .c 3624 to 4171 2 to 550   tiling clone, capped   549/549
(100 %)
2 diff
(99.7 %id)
BF351135 head_neck .c 3813 to 3927 116 to 1       116/116
(100 %)
1 diff
(99.2 %id)
TI_1948148282   .c 4312 to 5147 960 to 125   tiling clone,   836/1418
(58 %)
37 diff
(97.4 %id)
TI_1948148583   .c 4312 to 5148 958 to 124   tiling clone,   835/1340
(62 %)
6 diff
(99.6 %id)
TI_1948149200   .c 4313 to 5148 960 to 128       833/1418
(58 %)
11 diff
(99.3 %id)
BG121200 adenocarcinoma, cell line, Liver .c 4320 to 5079 1 to 752   tiling clone,   752/757
(99 %)
17 diff
(97.8 %id)
CX782782 human embryonic stem cells .c 4331 to 5157 1 to 827   tiling clone, fully sequenced,   827/827
(100 %)
1 diff
(99.9 %id)
BI223377 cervical carcinoma cell line, cervix .c 4346 to 5251 1 to 910       910/910
(100 %)
16 diff
(98.3 %id)
TI_1948148874   .c 4430 to 5148 846 to 123       724/1473
(49 %)
15 diff
(99.0 %id)
BE047638 brain, tumor, 5 pooled (see description) .c 4455 to 4943 7 to 495       489/495
(98 %)
7 diff
(98.6 %id)
TI_1948148582   .c 4485 to 5148 773 to 111       663/1346
(49 %)
13 diff
(99.1 %id)
BE730520 choriocarcinoma, placenta .c 4613 to 5414 1 to 788       788/978
(80 %)
25 diff
(97.5 %id)
BP215449 corpus callosum .c 4642 to 5222 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BG677412 skin, squamous cell carcinoma .c 4645 to 5467 1 to 823       823/823
(100 %)
3 diff
(99.7 %id)
R07447 liver and spleen .c 4701 to 4994 1 to 298       298/316
(94 %)
10 diff
(96.9 %id)
AA403066   .c 4739 to 4972 1 to 233       233/233
(100 %)
2 diff
(99.2 %id)
BQ348007 head_neck .c 4742 to 4949 1 to 206       206/206
(100 %)
12 diff
(94.2 %id)
BM797529 Ascites, stomach .c 4770 to 4953 1 to 184       184/184
(100 %)
0 diff
(100 %id)
DB313251 tongue, tumor tissue .c 5072 to 5644 573 to 1   to resequence,   573/573
(100 %)
0 diff
(100 %id)
N45311 multiple sclerosis lesions .c 5109 to 5762 652 to 1       652/679
(96 %)
36 diff
(94.7 %id)
CX782705 human embryonic stem cells .c 5139 to 5763 653 to 29   tiling clone, fully sequenced,   625/653
(95 %)
0 diff
(100 %id)
AA398414   .c 5286 to 5644 359 to 1       359/359
(100 %)
0 diff
(100 %id)
N91133 lung .c 5299 to 5764 463 to 1   tiling clone,   463/472
(98 %)
3 diff
(99.4 %id)
AI867088 brain, tumor, 5 pooled (see description) .c 5370 to 5763 394 to 1       394/394
(100 %)
0 diff
(100 %id)
BI085220 astrocytoma grade IV, cell line, brain .d 1 to 734 1 to 751   tiling clone,   751/947
(79 %)
45 diff
(95.3 %id)
AA159854 Pancreas .d 618 to 1013 14 to 404   tiling clone,   391/406
(96 %)
14 diff
(96.6 %id)
W31874 parathyroid gland, parathyroid tumor .d 626 to 743 1 to 120   tiling clone,   120/131
(91 %)
9 diff
(93.2 %id)
BI085866 astrocytoma grade IV, cell line, brain .d 2115 to 2733 653 to 19   tiling clone,   635/656
(96 %)
0 diff
(100 %id)
W16858 parathyroid gland, parathyroid tumor .d 2288 to 2682 398 to 1   tiling clone,   398/398
(100 %)
7 diff
(98.3 %id)
AA158737 Pancreas .d 2365 to 2740 376 to 1   tiling clone,   376/376
(100 %)
2 diff
(99.5 %id)
AL133017 testis .e 1 to 4225 1 to 4225 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 4225/4225
(100 %)
0 diff
(100 %id)
BF883421 lung_tumor .e 1695 to 2100 22 to 430       409/430
(95 %)
6 diff
(98.7 %id)
DB053588 testis .f 1 to 569 2 to 571   tiling clone, capped   570/570
(100 %)
3 diff
(99.5 %id)
DB338746 testis .f 1281 to 1816 538 to 1   tiling clone,   538/538
(100 %)
3 diff
(99.5 %id)
AL530020 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 1 to 819 1 to 819   tiling clone, fully sequenced,   819/819
(100 %)
7 diff
(99.2 %id)
AL525887 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 46 to 835 1 to 790   fully sequenced,   790/790
(100 %)
0 diff
(100 %id)
AK026518   .g 60 to 1698 1 to 1639 exact tiling clone, available from FLJ, AAA   1639/1639
(100 %)
2 diff
(99.9 %id)
AL530648 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 74 to 907 1 to 835   fully sequenced,   835/835
(100 %)
10 diff
(98.9 %id)
AL528085 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 81 to 907 1 to 827   fully sequenced,   827/827
(100 %)
6 diff
(99.3 %id)
BM857572 insulinoma, Pancreas .g 87 to 546 1 to 460       460/460
(100 %)
5 diff
(99.0 %id)
AL530206 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 88 to 890 1 to 800       800/1030
(77 %)
11 diff
(99.0 %id)
BM913518 amelanotic melanoma, cell line, skin .g 503 to 1429 1 to 930       928/1092
(84 %)
10 diff
(99.1 %id)
AL523788 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 605 to 1678 1065 to 1       1065/1146
(92 %)
34 diff
(97.1 %id)
BX366059 Neuroblastoma Cot 25-normalized .g 673 to 1664 992 to 1       992/1037
(95 %)
26 diff
(97.5 %id)
AL525841 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 805 to 1644 869 to 30   fully sequenced,   840/869
(96 %)
2 diff
(99.8 %id)
AL563622 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 809 to 1683 875 to 1   fully sequenced,   875/875
(100 %)
14 diff
(98.4 %id)
AL528084 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 846 to 1667 820 to 1   fully sequenced,   820/820
(100 %)
12 diff
(98.6 %id)
AL530647 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 846 to 1659 813 to 1   fully sequenced,   743/743
(100 %)
17 diff
(97.8 %id)
AL530205 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 863 to 1664 800 to 1       800/1144
(69 %)
27 diff
(97.7 %id)
AI741904 pooled .g 998 to 1697 704 to 9       696/721
(96 %)
19 diff
(97.4 %id)
AW246206 lung, small cell carcinoma .g 1010 to 1310 1 to 301   fully sequenced,   301/301
(100 %)
5 diff
(98.4 %id)
BU621380 cell lines, Chondrosarcoma .g 1055 to 1698 662 to 19   AAA   644/646
(99 %)
3 diff
(99.6 %id)
BM508229 insulinoma, Pancreas .g 1105 to 1698 617 to 24   AAA   594/594
(100 %)
3 diff
(99.5 %id)
BU942060 mixed (pool of 40 RNAs) .g 1111 to 1723 1 to 613       613/647
(94 %)
6 diff
(99.1 %id)
BM857457 insulinoma, Pancreas .g 1114 to 1698 608 to 24   AAA   585/585
(100 %)
3 diff
(99.5 %id)
BM194562 leukopheresis .g 1141 to 1713 1 to 574       574/574
(100 %)
5 diff
(99.2 %id)
BM153565 leukopheresis .g 1141 to 1721 1 to 582       582/584
(99 %)
20 diff
(96.6 %id)
BG008706 placenta_normal .g 1152 to 1512 360 to 1       360/360
(100 %)
17 diff
(95.3 %id)
BF760075 colon .g 1246 to 1663 424 to 8     Submitted on the opposite strand 417/424
(98 %)
0 diff
(100 %id)
AW249939 lung, small cell carcinoma .g 1249 to 1695 457 to 11   fully sequenced, AAA   447/447
(100 %)
4 diff
(99.2 %id)
AI262225 Kidney .g 1252 to 1697 449 to 5       445/449
(99 %)
1 diff
(99.8 %id)
AA631248 colon, colon tumor RER+ .g 1253 to 1710 473 to 17   AAA   457/457
(100 %)
4 diff
(99.2 %id)
AI379987 B-cell, chronic lymphotic leukemia .g 1266 to 1697 430 to 1       430/430
(100 %)
4 diff
(99.1 %id)
AI076571 liver and spleen .g 1273 to 1693 425 to 5       421/425
(99 %)
0 diff
(100 %id)
AA747742 pooled germ cell tumors .g 1299 to 1695 397 to 1       397/397
(100 %)
4 diff
(99.0 %id)
BM929837 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 1306 to 1698 1 to 393   AAA   393/393
(100 %)
1 diff
(99.8 %id)
AI039409   .g 1307 to 1699 398 to 6       393/398
(98 %)
0 diff
(100 %id)
AW182741 cervix, tumor .g 1307 to 1699 393 to 1       393/393
(100 %)
3 diff
(99.3 %id)
AA316496 colon .g 1361 to 1597 1 to 237       237/237
(100 %)
2 diff
(99.2 %id)
AI470348 pooled .g 1403 to 1696 304 to 11   AAA   294/294
(100 %)
1 diff
(99.7 %id)
AI266555 2 pooled tumors (clear cell type), Kidney .g 1404 to 1699 302 to 7       296/302
(98 %)
0 diff
(100 %id)
CA429822 Cell Line, Chondrosarcoma .g 1427 to 1698 287 to 17   AAA   271/271
(100 %)
2 diff
(99.3 %id)
BP313739 mammary gland .h 1 to 580 1 to 581   tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
AL523400 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .h 148 to 1215 1 to 1064   tiling clone,   1064/1086
(97 %)
13 diff
(98.9 %id)
BP358072 mammary gland .h 265 to 845 1 to 581   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
BM702033 eye, optic nerve .i 1 to 625 1 to 625   tiling clone, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 625/625
(100 %)
1 diff
(99.9 %id)
BM666622 eye, optic nerve .i 1198 to 1709 530 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 512/512
(100 %)
0 diff
(100 %id)
BM153288 leukopheresis .j 1 to 554 1 to 554   tiling clone,   554/554
(100 %)
14 diff
(97.5 %id)
BM193009 leukopheresis .j 1 to 390 1 to 389   tiling clone,   389/447
(87 %)
18 diff
(96.0 %id)
DA417429 thalamus .j 379 to 936 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
AA161002 Pancreas .j 773 to 970 1 to 198       198/198
(100 %)
0 diff
(100 %id)
AA161059 Pancreas .j 773 to 1122 1 to 356   tiling clone,   356/362
(98 %)
10 diff
(97.3 %id)
AA161020 Pancreas .j 2247 to 2646 400 to 1   tiling clone,   400/401
(99 %)
2 diff
(99.6 %id)
AA161060 Pancreas .j 2248 to 2646 398 to 1   tiling clone,   398/398
(100 %)
2 diff
(99.5 %id)
BM837398 Ascites, stomach .k 1 to 557 1 to 557   tiling clone,   557/557
(100 %)
7 diff
(98.8 %id)
BE707258 head_neck .k 356 to 794 458 to 1   tiling clone,   458/459
(99 %)
41 diff
(91.1 %id)
CN358483 embryonic stem cells, cell lines H1, H7, andH9 .l 1 to 586 1 to 584   tiling clone,   584/584
(100 %)
6 diff
(99.0 %id)
TI_57163226   .l 125 to 1041 25 to 947 exact tiling clone,   923/948
(97 %)
17 diff
(98.3 %id)
BI837872 pooled pancreas and spleen .l 130 to 1041 1 to 918 exact tiling clone,   918/919
(99 %)
11 diff
(98.9 %id)
AL523399 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .l 205 to 1324 1105 to 1   tiling clone,   1050/1112
(94 %)
21 diff
(98.2 %id)
DB224426 trachea .m 1 to 555 2 to 557   tiling clone, capped   556/556
(100 %)
2 diff
(99.7 %id)
BM475391 eye, retinoblastoma .m 221 to 987 1 to 770 V157G A158G T159Q S160L P161N ... tiling clone,   770/1110
(69 %)
19 diff
(98.3 %id)
CD632455   .n 1 to 558 572 to 15 exact tiling clone,   558/572
(97 %)
0 diff
(100 %id)
CD632456   .n 1 to 558 1 to 557 E22S Y23T L24S R25E E26K ...     557/574
(97 %)
4 diff
(99.4 %id)
AK299802 brain .o 1 to 1186 1 to 1186 exact tiling clone,   1186/1186
(100 %)
2 diff
(99.9 %id)
DA800682 brain .o 2 to 552 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BG779261 adenocarcinoma, Prostate .p 1 to 713 1 to 713   tiling clone,   713/714
(99 %)
2 diff
(99.8 %id)
BU528139 epidermoid carcinoma, cell line, lung .p 14 to 919 20 to 927   tiling clone,   907/927
(97 %)
16 diff
(98.3 %id)
BU526810 epidermoid carcinoma, cell line, lung .p 20 to 866 1 to 853       853/935
(91 %)
26 diff
(97.3 %id)
BU528583 epidermoid carcinoma, cell line, lung .p 20 to 964 1 to 949 P82S S131X E133K G137E S155L ... tiling clone,   949/949
(100 %)
13 diff
(98.7 %id)
BU528655 epidermoid carcinoma, cell line, lung .p 20 to 914 1 to 894   tiling clone,   894/894
(100 %)
2 diff
(99.8 %id)
BM547221 ovary (pool of 3) .q 1 to 939 6 to 945   tiling clone,   945/1106
(85 %)
27 diff
(97.6 %id)
BG760488 melanotic melanoma, high MDR (cell line), skin .q 72 to 876 1 to 804       804/804
(100 %)
6 diff
(99.3 %id)
BG760218 melanotic melanoma, high MDR (cell line), skin .q 72 to 821 1 to 747       747/748
(99 %)
8 diff
(99.0 %id)
BG760985 melanotic melanoma, high MDR (cell line), skin .q 72 to 929 1 to 850   tiling clone,   853/950
(89 %)
27 diff
(97.2 %id)
BG764087 melanotic melanoma, high MDR (cell line), skin .q 72 to 863 1 to 791   tiling clone,   791/795
(99 %)
5 diff
(99.4 %id)
BG766122 melanotic melanoma, high MDR (cell line), skin .q 72 to 958 1 to 891 S26G E44* tiling clone,   891/924
(96 %)
18 diff
(98.1 %id)
BG765251 melanotic melanoma, high MDR (cell line), skin .q 72 to 911 1 to 839       839/840
(99 %)
14 diff
(98.4 %id)
BG765485 melanotic melanoma, high MDR (cell line), skin .q 72 to 789 1 to 732       732/895
(81 %)
23 diff
(97.5 %id)
BG767396 melanotic melanoma, high MDR (cell line), skin .q 72 to 844 1 to 798       798/832
(95 %)
50 diff
(94.0 %id)
BG769030 melanotic melanoma, high MDR (cell line), skin .q 72 to 902 1 to 829   tiling clone,   829/829
(100 %)
9 diff
(99.0 %id)
BG767948 melanotic melanoma, high MDR (cell line), skin .q 72 to 841 1 to 772       772/788
(97 %)
8 diff
(99.0 %id)
DN997619 breast cancer, Mammary gland (cancer tissue) .q 78 to 779 20 to 721   tiling clone,   702/721
(97 %)
10 diff
(98.7 %id)
DB279492 uterus .q 109 to 643 2 to 536   tiling clone, capped   535/535
(100 %)
1 diff
(99.9 %id)
BG678768 skin, squamous cell carcinoma .r 1 to 839 1 to 851 L29A Q30A T31D R32Q L33A ... tiling clone,   851/856
(99 %)
36 diff
(95.8 %id)
BE548809 cervical carcinoma cell line, cervix .r 328 to 1065 1 to 739 L40F     739/739
(100 %)
11 diff
(98.6 %id)
BE789285 large cell carcinoma, lung .r 341 to 1123 1 to 787       787/888
(88 %)
26 diff
(97.1 %id)
BE548314 cervical carcinoma cell line, cervix .r 392 to 1138 1 to 750   tiling clone,   750/753
(99 %)
12 diff
(98.5 %id)
BP429225   .r 399 to 795 1 to 397       397/397
(100 %)
2 diff
(99.5 %id)
BE926161 breast_normal .r 400 to 662 1 to 263       263/263
(100 %)
7 diff
(97.4 %id)
TI_149315811   .r 441 to 1386 1015 to 82   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 934/1030
(90 %)
25 diff
(97.6 %id)
TI_154102651   .r 446 to 1268 887 to 79   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 809/810
(99 %)
36 diff
(95.6 %id)
BE871805 adenocarcinoma, colon .r 453 to 1161 1 to 708       708/967
(73 %)
14 diff
(98.6 %id)
BQ331714 lung_tumor .r 456 to 844 1 to 387       387/387
(100 %)
5 diff
(98.8 %id)
BE788550 large cell carcinoma, lung .r 473 to 1234 1 to 756       756/944
(80 %)
25 diff
(97.4 %id)
TI_154110591   .r 489 to 1386 948 to 61   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 888/994
(89 %)
15 diff
(98.5 %id)
BF888287 testis_normal .r 490 to 670 186 to 8     Submitted on the opposite strand 179/186
(96 %)
0 diff
(100 %id)
BE837697 prostate_normal .r 506 to 855 358 to 9       350/359
(97 %)
3 diff
(99.2 %id)
BM194588 leukopheresis .r 515 to 1083 569 to 1       569/569
(100 %)
4 diff
(99.3 %id)
BG576305 breast, mammary adenocarcinoma, cell line .r 532 to 1307 1 to 776       776/777
(99 %)
5 diff
(99.4 %id)
BM152769 leukopheresis .r 539 to 1083 546 to 1       546/546
(100 %)
5 diff
(99.1 %id)
BM147237 leukopheresis .r 549 to 1083 536 to 1       536/537
(99 %)
4 diff
(99.3 %id)
BM193103 leukopheresis .r 556 to 1083 528 to 1       528/528
(100 %)
5 diff
(99.1 %id)
BM152369 leukopheresis .r 562 to 1083 522 to 1       522/542
(96 %)
6 diff
(98.9 %id)
BM689656 eye, Retina Foveal and Macular .r 584 to 843 8 to 267   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 260/267
(97 %)
6 diff
(97.8 %id)
BM150324 leukopheresis .r 585 to 1083 499 to 1       499/499
(100 %)
8 diff
(98.4 %id)
R17090 liver and spleen .r 594 to 958 1 to 374       374/461
(81 %)
16 diff
(96.6 %id)
BM147171 leukopheresis .r 595 to 1083 489 to 1       489/489
(100 %)
5 diff
(99.0 %id)
AA007287 liver and spleen .r 598 to 828 1 to 238   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 238/238
(100 %)
2 diff
(99.2 %id)
AA004273 liver and spleen .r 798 to 1268 500 to 26   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 475/475
(100 %)
5 diff
(99.0 %id)
BM661625 eye, Retina Foveal and Macular .r 813 to 1268 474 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 456/456
(100 %)
0 diff
(100 %id)
R17091 liver and spleen .r 1033 to 1388 365 to 1   tiling clone,   365/381
(95 %)
10 diff
(97.4 %id)
DA459812 tongue, tumor tissue .s 1 to 557 2 to 558   tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
CX761320 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .s 10 to 725 1 to 719   tiling clone, Submitted on the opposite strand 716/719
(99 %)
1 diff
(99.9 %id)
BU509222 leiomyosarcoma, uterus .s 38 to 709 1 to 672 N116K V117C K118Q S131X S134E ... tiling clone,   799/863
(92 %)
11 diff
(98.8 %id)
TI_154101508   .t-u 1 to 670 725 to 62 exact tiling clone, AAA   664/785
(84 %)
10 diff
(98.8 %id)
CA441955 Chondrosarcoma, Left Pubic Bone .t-u 139 to 670 549 to 17 exact tiling clone, AAA   533/533
(100 %)
1 diff
(99.9 %id)
BI047691 stomach .t-u 430 to 636 27 to 232       206/232
(88 %)
6 diff
(97.5 %id)
BF375401 stomach .t-u 438 to 636 1 to 206       206/206
(100 %)
13 diff
(93.7 %id)
BI047413 stomach .t-u 439 to 606 168 to 1       168/168
(100 %)
2 diff
(98.9 %id)
BM144945 leukopheresis .u 1 to 465 1 to 465 Q14L tiling clone,   465/465
(100 %)
2 diff
(99.6 %id)
BE243727 leukopheresis .u 1 to 424 1 to 424 A34V     424/424
(100 %)
1 diff
(99.8 %id)
BE246277 leukopheresis .u 1 to 376 1 to 376   tiling clone,   376/378
(99 %)
1 diff
(99.8 %id)
BM193094 leukopheresis .u 1 to 433 1 to 433 G32V W37C N68T N69X C103R ...     433/433
(100 %)
21 diff
(95.2 %id)
BF762988 colon_est .u 367 to 852 12 to 497       486/497
(97 %)
6 diff
(98.8 %id)
DB113084 thymus .u 415 to 995 2 to 582   tiling clone, capped   581/581
(100 %)
0 diff
(100 %id)
BI758724 brain .va 1 to 758 1 to 759   tiling clone, available from MGC,   759/763
(99 %)
4 diff
(99.5 %id)
TI_57216447   .va 1 to 758 1 to 759       759/763
(99 %)
4 diff
(99.5 %id)
BC036325 Brain, adult, 6 pooled whole brains .va 4 to 1969 1 to 1967 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (39/41 A in genome downstream of last aligned base) 1967/1967
(100 %)
1 diff
(100.0 %id)
DW415702 Liver .va 823 to 1118 17 to 312       296/312
(94 %)
6 diff
(98.1 %id)
DW445567 Liver .va 823 to 1027 17 to 221       205/221
(92 %)
6 diff
(97.3 %id)
DW451033 Liver .va 823 to 1001 17 to 195       179/195
(91 %)
6 diff
(97.0 %id)
BF380920 uterus_tumor .va 993 to 1425 1 to 435       435/435
(100 %)
13 diff
(97.1 %id)
T47918 fetal spleen, Spleen .va 1021 to 1368 1 to 360       360/363
(99 %)
13 diff
(96.5 %id)
BF058513 fibrotheoma, ovary .va 1269 to 1536 1 to 268     Submitted on the opposite strand 268/268
(100 %)
0 diff
(100 %id)
AI650341 Kidney .va 1874 to 2380 506 to 1   tiling clone,   506/506
(100 %)
6 diff
(98.9 %id)
BE326687 Kidney .va 1996 to 2380 386 to 1   tiling clone,   386/415
(93 %)
2 diff
(99.6 %id)
CA450578 Human Lung Epithelial cells, lung .va 1998 to 2380 401 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 383/392
(97 %)
7 diff
(98.3 %id)
AA933866 2 pooled tumors (clear cell type), Kidney .va 2032 to 2383 352 to 1   tiling clone,   352/352
(100 %)
0 diff
(100 %id)
AW137772   .va 2039 to 2380 353 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 336/346
(97 %)
8 diff
(97.7 %id)
AI570337 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .va 2051 to 2380 331 to 1       331/331
(100 %)
1 diff
(99.7 %id)
AI968790 pooled germ cell tumors .va 2067 to 2380 314 to 1       314/314
(100 %)
0 diff
(100 %id)
BE504283 carcinoid, lung .va 2072 to 2379 302 to 1       302/302
(100 %)
4 diff
(98.7 %id)
DA834012 placenta .va 2135 to 2968 2 to 830   capped   829/829
(100 %)
7 diff
(99.2 %id)
BU680500 lung .va 2171 to 2380 229 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 211/213
(99 %)
4 diff
(98.2 %id)
AW967737   .va 2356 to 2963 1 to 608   tiling clone,   608/608
(100 %)
1 diff
(99.9 %id)
AW967738   .va 2356 to 2994 1 to 640       640/640
(100 %)
9 diff
(98.6 %id)
AW967742   .va 2356 to 2871 1 to 517       517/518
(99 %)
7 diff
(98.7 %id)
AW971591   .va 2356 to 2867 1 to 512       512/512
(100 %)
14 diff
(97.3 %id)
BG819037 anaplastic oligodendroglioma with 1p/19qloss, brain .va 2505 to 3222 1 to 715   tiling clone,   715/719
(99 %)
7 diff
(99.1 %id)
DW417913 Liver .va 2728 to 3015 16 to 304       289/304
(95 %)
6 diff
(98.1 %id)
BP344641 synovial membrane .va 3027 to 3605 1 to 579   tiling clone,   579/579
(100 %)
2 diff
(99.7 %id)
BG182302   .va 3556 to 3871 21 to 337   tiling clone,   317/337
(94 %)
6 diff
(98.3 %id)
BQ924101 sciatic nerve .vb-u 1 to 881 12 to 909 G39X S45L L57P A58S G59W ... tiling clone,   898/920
(97 %)
30 diff
(96.8 %id)
DA808564 brain .vb-u 71 to 600 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
BE172217 head_neck .vb-u 417 to 664 259 to 10   tiling clone, Submitted on the opposite strand 250/271
(92 %)
0 diff
(100 %id)
BX462908 fetal liver, Liver .vc 1 to 989 1 to 980   tiling clone,   980/980
(100 %)
11 diff
(98.9 %id)
DA794200 brain .vc 47 to 626 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BX431741 fetal liver, Liver .vc 812 to 1775 1 to 968   tiling clone,   968/968
(100 %)
60 diff
(93.9 %id)
CN272131 embryonic stem cells, DMSO-treated H9 cellline .vc 1034 to 1782 1 to 749   tiling clone,   749/749
(100 %)
5 diff
(99.4 %id)
BF989893 placenta_normal .vc 1222 to 1571 364 to 14       351/374
(93 %)
0 diff
(100 %id)
BF999308 placenta_normal .vc 1222 to 1571 364 to 14       351/374
(93 %)
0 diff
(100 %id)
DB326651 brain .vc 1807 to 2353 547 to 1   tiling clone,   547/547
(100 %)
2 diff
(99.7 %id)
AL703520 human skeletal muscle .vd 1 to 601 1 to 601 exact tiling clone,   601/601
(100 %)
3 diff
(99.6 %id)
BF351112 head_neck .vd 197 to 575 387 to 4       384/387
(99 %)
11 diff
(97.2 %id)
BE162675 head_neck .vd 268 to 575 312 to 4     Submitted on the opposite strand 309/312
(99 %)
2 diff
(99.4 %id)
CD515114 White Matter .ve 1 to 846 1 to 855 exact tiling clone,   855/926
(92 %)
10 diff
(99.0 %id)
DB289349 uterus .vf 1 to 568 2 to 569 exact tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BF913347 uterus_tumor .vf 197 to 710 1 to 513       513/513
(100 %)
4 diff
(99.3 %id)
DA452469 tongue, tumor tissue .vf 219 to 777 2 to 561   tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
CN287270 embryonic stem cells, cell lines H1, H7, andH9 .vf 731 to 1001 1 to 271   tiling clone,   271/271
(100 %)
0 diff
(100 %id)
R62201 placenta .vg-u 1 to 439 1 to 456   tiling clone,   456/465
(98 %)
27 diff
(94.2 %id)
R64586 placenta .vg-u 687 to 871 193 to 9   tiling clone,   185/193
(95 %)
0 diff
(100 %id)
DB099545 testis .vh 1 to 569 6 to 574 exact tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
BF990203 placenta_normal .vh 320 to 800 12 to 491   tiling clone,   480/491
(97 %)
6 diff
(98.8 %id)
BF993520 placenta_normal .vh 325 to 648 1 to 324       324/324
(100 %)
7 diff
(97.9 %id)
BF993600 placenta_normal .vh 335 to 770 1 to 434       434/434
(100 %)
5 diff
(98.9 %id)
BF993568 placenta_normal .vh 344 to 635 1 to 293       293/293
(100 %)
14 diff
(95.3 %id)
BQ370365 placenta_normal .vh 353 to 717 27 to 399       373/399
(93 %)
6 diff
(98.5 %id)
BF992709 placenta_normal .vh 356 to 757 28 to 432       405/432
(93 %)
6 diff
(98.7 %id)
BQ370367 placenta_normal .vh 376 to 756 1 to 379       379/379
(100 %)
17 diff
(95.6 %id)
BQ370368 placenta_normal .vh 403 to 768 1 to 368       368/368
(100 %)
7 diff
(98.1 %id)
BE898142 melanotic melanoma, skin .vi 1 to 746 1 to 749 L2S Q15P A16C R17Q E18V ... tiling clone,   749/790
(94 %)
24 diff
(97.0 %id)
DB024054 testis .vj 1 to 432 2 to 433 exact tiling clone, capped   432/549
(78 %)
0 diff
(100 %id)
BX492692   .vj 35 to 613 1 to 583   tiling clone,   583/583
(100 %)
5 diff
(99.2 %id)
DB012843 esophageal, tumor tissue .vk 1 to 564 2 to 565 S29L tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
DA514672 brain .vl 1 to 547 2 to 548 exact tiling clone, capped   547/548
(99 %)
2 diff
(99.7 %id)
BQ349706 head_neck .vl 38 to 435 6 to 403       398/404
(98 %)
8 diff
(98.1 %id)
DB447820 testis .vm 1 to 446 1 to 446 exact tiling clone,   446/446
(100 %)
2 diff
(99.6 %id)
AV709284 adrenal gland Gene MYO19, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AL049275.
matches multiple genes
brain Gene womy, variant not shown       available from DKFZ, AAA This clone was ignored, also hits gene womy    
AL049275.
matches multiple genes
brain Gene MYO19, variant not shown       available from DKFZ, AAA This clone was ignored, also hits gene womy    
AW385193 head_neck Gene MYO19, variant not shown         This clone was ignored    
BF809307 colon_ins Gene MYO19, variant not shown       AAA Submitted on the opposite strand, submitted on the opposite strand    
DC306815 cerebellum Gene MYO19, variant not shown         This clone was ignored    
DC308688 cerebellum Gene MYO19, variant not shown         This clone was ignored    
DC324442 brain Gene MYO19, variant not shown         This clone was ignored    
DC332303 hippocampus Gene MYO19, variant not shown         This clone was ignored    
DC332928 hippocampus Gene MYO19, variant not shown         This clone was ignored    
DC334850 hippocampus Gene MYO19, variant not shown         This clone was ignored    
DC335230 hippocampus Gene MYO19, variant not shown         This clone was ignored    
DC342308 thalamus Gene MYO19, variant not shown         This clone was ignored    
CN366388 embryonic stem cells, cell lines H1, H7, andH9 Gene MYO19, variant not shown              
DC347740 tongue, tumor tissue Gene MYO19, variant not shown         This clone was ignored    
BP232782 muscle Gene MYO19, variant not shown         Suspected internal deletion, this clone was ignored    
R08484 liver and spleen Gene MYO19, variant not shown         Suspected internal deletion, this clone was ignored    
N50437 multiple sclerosis lesions Gene MYO19, variant not shown         This clone was ignored    
N50493 multiple sclerosis lesions Gene MYO19, variant not shown         This clone was ignored    
AA514498 colon Gene MYO19, variant not shown         This clone was ignored    
AA628030 colon, colon tumor RER+ Gene MYO19, variant not shown         Suspected internal deletion, this clone was ignored    
BC040477 lung Gene MYO19, variant not shown       available from MGC, AAA This clone was ignored    
BC041980 Brain, hypothalamus Gene MYO19, variant not shown       available from MGC, AAA This clone was ignored    
BQ054717 lymph, lymphoma, cell line Gene MYO19, variant not shown         This clone was ignored    
BQ062891 lymph, lymphoma, cell line Gene MYO19, variant not shown         This clone was ignored    
NM_025109.5   Gene MYO19, variant not shown       RefSeq, AAA This clone was ignored    
NM_001033580.2   Gene MYO19, variant not shown       RefSeq, AAA This clone was ignored    
NM_001163735.1   Gene MYO19, variant not shown       RefSeq, AAA This clone was ignored    
DC377101 brain Gene MYO19, variant not shown         This clone was ignored    
BM147029 leukopheresis Gene MYO19, variant not shown         This clone was ignored    
DC404112 testis Gene MYO19, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t-u, .u, .va, .vb-u, .vc, .vd, .ve, .vf, .vg-u, .vh, .vi, .vj, .vk, .vl, .vm Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C